Advicenne webcast – ADV7103: managing a US approval pathway to address unmet needs in rare renal disease
SAVE THE DATE
October 14, 2024 at 6PM CET
Web link
ADV7103: managing a US approval pathway to address unmet needs in rare renal disease
ADVICENNE’s management will discuss the recent announcement about its successes in the USA, and the next steps in the development of its main asset, ADV7103, both in Europe and in the USA.